Published in Gematol Transfuziol on December 01, 1985
[Change in the immunoglobulins and nonspecific defense factors in hypoplastic anemia]. Probl Gematol Pereliv Krovi (1980) 0.75
[Bone marrow transplantation in the treatment of aplastic anemia patients]. Ter Arkh (1993) 0.75
[Prevention and treatment of hemodynamic disorders in subacute hypoplastic anemia after splenectomy]. Probl Gematol Pereliv Krovi (1976) 0.75
[Clinico-immunologic aspects of idiopathic neutropenias]. Klin Med (Mosk) (1990) 0.75
[Determination of the activity of the pathologic process in hypoplastic (aplastic) anemia]. Gematol Transfuziol (1993) 0.75
[Pathogenesis of the development of fibroreticular tissue in patients with chronic myeloleukemia]. Gematol Transfuziol (1988) 0.75
[Indications for using androgens in hypoplastic anemia]. Gematol Transfuziol (1984) 0.75
[Surgical results with hematologic patients]. Vestn Khir Im I I Grek (1982) 0.75
[Electron microscopic characteristics of bone marrow lymphocytes in hypo- and aplastic anemias]. Probl Gematol Pereliv Krovi (1978) 0.75
[Transition of hypoplastic anemia into acute leukemia]. Probl Gematol Pereliv Krovi (1968) 0.75
[Colony-forming capacity of bone marrow cells in patients with hypoplastic anemia]. Gematol Transfuziol (1984) 0.75
[Hemopoiesis in hypoplastic and aplastic anemia according to the puncture material and sections of bone marrow trephination material]. Probl Gematol Pereliv Krovi (1967) 0.75
[Successful treatment of a patient having partial hypoplastic anemia with cyclophosphan]. Probl Gematol Pereliv Krovi (1976) 0.75
[Treatment principles and procedure in hypoplastic anemia]. Sov Med (1981) 0.75
[Thrombocyte ultrastructural and functional characteristics in hypoplastic anemia patients]. Probl Gematol Pereliv Krovi (1981) 0.75
[The role of splenectomy in treating severe aplastic anemia]. Gematol Transfuziol (1996) 0.75
[Phagocytosis and bactericidal properties of the blood serum in hypoplastic hemopoiesis]. Ter Arkh (1970) 0.75
[Characteristics of the immunohematological indicators in patients with hypoplastic anemia during remission]. Gematol Transfuziol (1983) 0.75
[Vitamin B 12 and serum protein content of the blood in hypo- and aplastic anemias]. Probl Gematol Pereliv Krovi (1970) 0.75
[A method of differentiated combined treatment of patients with hypoplastic anemia after splenectomy]. Gematol Transfuziol (1983) 0.75
[Effect of combined treatment on erythrocyte life span in hypoplastic anemia]. Probl Gematol Pereliv Krovi (1980) 0.75
[Valve of the radioisotope method of study in the determination of indications for splenectomy in patients with hypo- and aplastic anemia]. Probl Gematol Pereliv Krovi (1975) 0.75
[Levamisole in the treatment of hypoplastic anemia]. Gematol Transfuziol (1984) 0.75
[Myelocytic leukemia transformed into reticulosarcomatosis]. Ter Arkh (1976) 0.75
[Splenectomy in the treatment of hypo- and aplastic anemia]. Sov Med (1970) 0.75
[Diagnostic value of the study of material of trephine biopsies in patients with hypo- and aplastic anemia]. Probl Gematol Pereliv Krovi (1975) 0.75
[Basic principles of blood transfusion therapy in splenectomy on hypoplastic anemia patients]. Probl Gematol Pereliv Krovi (1978) 0.75
[Complications of an ulcerative-necrotic lesion of the gastrointestinal tract in hemoblastosis patients]. Probl Gematol Pereliv Krovi (1981) 0.75
[The use of cyclophosphane in the immunodepressive therapy of severe aplastic anemia]. Ter Arkh (1997) 0.75
[Bacterial flora and certain indicators of nonspecific reactivity of the body in hypo-aplastic anemias]. Probl Gematol Pereliv Krovi (1973) 0.75
[Cyclophosphane treatment of patients with partial red cell aplasia]. Gematol Transfuziol (1987) 0.75
[New trends in the treatment of hypoplastic anemia]. Klin Med (Mosk) (1985) 0.75
[Tactics of the surgeon during performance of splenectomy in patients with hypo- and aplastic anemia]. Probl Gematol Pereliv Krovi (1968) 0.75
[Granulocyte ultrastructure in patients with hypoplastic anemia]. Gematol Transfuziol (1983) 0.75